Delivery Order 36C26325D0021-36C26326N0261
- Not listed
- Caredx, Inc., a medical technology company specializing in advanced diagnostic solutions for organ transplant patients, received a purchase order valued at $66,908.60 from the Veterans Integrated Service Network 17 (VISN 17) on December 15, 2023. The contract, which carries a firm fixed price structure with no set-aside designation, covers AlloSure kidney tests, AlloSure heart tests, and AlloMap heart tests. Performance is scheduled for completion by June 14, 2024, with services to be...
- CareDx, Inc. has been awarded a delivery order valued at $491,742.36 by the Department of Veterans Affairs through Veterans Integrated Service Network 9 (VISN 9) for genetic blood testing services for transplant patients. The contract, which carries a firm fixed-price structure with no set-aside designation, will be performed in Brisbane, California and is scheduled for completion by September 22, 2026. This delivery order falls under CareDx's larger Indefinite Delivery Contract with VISN 9,...
- This is a $193,171.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract is for laboratory reference testing services, specifically Caredx's specialized diagnostic solutions for organ transplant patients, including its AlloMap and AlloSure genetic and molecular testing products. The contract has an ultimate completion date of January 14,...
- This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
- This is a federal contract award to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $4,807,230.45, is for laboratory tests for post-transplant organ rejection and was awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of March 31, 2026....
- This federal contract award to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California, is for the provision of AlloSure kidney testing kits. The award, valued at $676,098.50, is a delivery order contract with a firm fixed price pricing type. The contracting agency is the Department of Veterans Affairs (VA) and the specific VA entity is Veterans Integrated Service Network 12 (VISN 12). The contract is not designated as a set-aside. Caredx has been awarded...
- The Department of Veterans Affairs (VA) has awarded a $18,466.34 firm-fixed-price delivery order contract to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide AlloMap molecular testing services for heart transplant patient monitoring. This delivery order is placed against a single-award indefinite delivery contract (IDC) valued at $787,000 that Caredx Lab Solutions holds with the VA's Veterans Integrated Service Network 17 (VISN 17), which runs through June 2027. The contract...
- This federal contract award is for "TRANSPLANT LABORATORY TESTING" services provided by Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services to support organ transplant programs. The contract, valued at $205,530.69, was awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract valued at...
- This federal contract award is for the delivery of TRANSPLANT TESTING KITS to the Veterans Integrated Service Network 12 (VISN 12), a division of the U.S. Department of Veterans Affairs (VA). The $849,384.25 fixed-price contract with economic price adjustment was awarded on September 30, 2025 to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract does not have a set-aside designation and has a period of performance through February 28,...
- This federal contract award is for the provision of TRANSPLANT TESTING KITS by Caredx, Inc., a for-profit organization that specializes in advanced medical testing products and services to support organ transplant programs. The contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), has a ceiling value of $2,397,593.00 and is structured as a Delivery Order on a Firm Fixed Price basis. The contract does not have a set-aside...
- 36C26325D0021Indefinite Delivery Contract
- 36C26325D0021-36C26326N0261Delivery Order
Caredx, Inc., a Brisbane, California-based medical technology company specializing in advanced diagnostic solutions for organ transplant patients, was awarded a delivery order valued at $142,037.50 by Veterans Integrated Service Network (VISN) 23 on January 15, 2026. The contract, which carries an ultimate completion date of January 14, 2028, is for AlloSure in-home patient testing services and operates under firm fixed pricing without a set-aside designation. The work will be performed in Iowa City, Iowa, supporting the Department of Veterans Affairs' mission to provide comprehensive post-transplant care to veteran patients across VISN 23's regional healthcare network. This delivery order falls under Caredx's larger Indefinite Delivery Contract with VISN 23, valued at $724,391, which enables the VA to issue task orders for the company's proprietary testing services on an as-needed basis. The award reflects the VA's continued reliance on Caredx's specialized diagnostic technologies, including the AlloSure kidney and heart tests, to monitor transplant recipients for organ rejection risks and improve patient outcomes. Caredx maintains multiple IDC vehicles across different VA regional networks and federal agencies, demonstrating the widespread adoption of its genetic and molecular testing platforms throughout the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $142.0k | 11/18/25 |